Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
PP-01 by Pleopharma for Substance (Drug) Abuse: Likelihood of Approval
PP-01 is under clinical development by Pleopharma and currently in Phase III for Substance (Drug) Abuse. According to GlobalData, Phase...